Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol.
Pain management
View this publicationPain management
View this publicationScientific reports
View this publicationPharmaceutics
View this publicationThe EMBO journal
View this publicationFrontiers in pharmacology
View this publicationCell death & disease
View this publicationInternational journal of molecular sciences
View this publicationBiology direct
View this publicationToxins
View this publicationThe EMBO journal
View this publication